Empresa Spark Therapeutics, Inc.
Acciones
US84652J1034
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ron Philip
CEO | Chief Executive Officer | - | 01/05/17 |
Gallia Levy
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 50 | 25/09/17 | |
Blake Sprayberry
PRN | Corporate Officer/Principal | - | - |
Chris Stevens
PRN | Corporate Officer/Principal | - | 01/01/22 |
Corporate Officer/Principal | - | 01/01/17 | |
Corporate Officer/Principal | - | 16/11/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Sean Johnston
BRD | Director/Board Member | - | 17/12/19 |
Bruce Resnick
BRD | Director/Board Member | - | 17/12/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 38 944 971 | 36 835 813 ( 94,58 %) | 421 677 ( 1,083 %) | 94,58 % |
Información de la empresa
Spark Therapeutics, Inc.
3737 Market Street Suite 1300
19104, Philadelphia
+215 220 9300
http://www.sparktx.com![Dirección Spark Therapeutics, Inc.](https://cdn.zonebourse.com/static/address/20798561.png)
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+16,25 % | 122 mil M | |
+19,28 % | 113 mil M | |
+18,95 % | 26,49 mil M | |
-23,42 % | 19,4 mil M | |
-19,03 % | 16,24 mil M | |
-19,88 % | 15,4 mil M | |
-46,14 % | 15,15 mil M | |
+64,11 % | 14,93 mil M | |
+4,68 % | 13,52 mil M |